LAMP5 Fine-Tunes GABAergic Synaptic Transmission in Defined Circuits of the Mouse Brain by Tiveron, Marie-Catherine et al.
HAL Id: hal-02332047
https://hal.archives-ouvertes.fr/hal-02332047
Submitted on 6 Jan 2020
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution| 4.0 International License
LAMP5 Fine-Tunes GABAergic Synaptic Transmission
in Defined Circuits of the Mouse Brain
Marie-Catherine Tiveron, Corinne Beurrier, Claire Ceni, Naly Andriambao,
Alexis Combes, Muriel Koehl, Nicolas Maurice, Evelina Gatti, Dhoher Nora
Abrous, Lydia Kerkerian-Le Goff, et al.
To cite this version:
Marie-Catherine Tiveron, Corinne Beurrier, Claire Ceni, Naly Andriambao, Alexis Combes, et al..
LAMP5 Fine-Tunes GABAergic Synaptic Transmission in Defined Circuits of the Mouse Brain. PLoS
ONE, Public Library of Science, 2016, 11 (6), pp.e0157052. ￿10.1371/journal.pone.0157052￿. ￿hal-
02332047￿
RESEARCH ARTICLE
LAMP5 Fine-Tunes GABAergic Synaptic
Transmission in Defined Circuits of the
Mouse Brain
Marie-Catherine Tiveron1*, Corinne Beurrier1, Claire Céni1, Naly Andriambao1,
Alexis Combes2, Muriel Koehl3, Nicolas Maurice1, Evelina Gatti2, Dhoher Nora Abrous3,
Lydia Kerkerian-Le Goff1, Philippe Pierre2, Harold Cremer1
1 Aix-Marseille University, Centre National pour la Recherche Scientifique, IBDM, Developmental Biology
Institute of Marseille, UMR 7288, 13009, Marseille, France, 2 Centre d’Immunologie de Marseille-Luminy,
Aix-Marseille Université UM2, Inserm U1104, CNRS UMR7280, 13288, Marseille, France, 3 Neurogenesis
and Physiopathology Group, INSERMU862, NeuroCentre Magendie, 33076, Bordeaux, France
*marie-catherine.tiveron@univ-amu.fr
Abstract
LAMP5 is member of the LAMP family of membrane proteins. In contrast to the canonical
members of this protein family, LAMP1 and LAMP2, which show widespread expression in
many tissues, LAMP 5 is brain specific in mice. In C. elegans, the LAMP5 ortholog UNC-46
has been suggested to act a trafficking chaperone, essential for the correct targeting of the
nematode vesicular GABA-transporter UNC-47. We show here that in the mouse brain
LAMP5 is expressed in subpopulations of GABAergic forebrain neurons in the striato-nigral
system and the olfactory bulb. The protein was present at synaptic terminals, overlapping
with the mammalian vesicular GABA-transporter VGAT. In LAMP5-deficient mice localiza-
tion of the transporter was unaffected arguing against a conserved role in VGAT trafficking.
Electrophysiological analyses in mutants showed alterations in short term synaptic plasticity
suggesting that LAMP5 is involved in controlling the dynamics of evoked GABAergic trans-
mission. At the behavioral level, LAMP5mutant mice showed decreased anxiety and defi-
cits in olfactory discrimination. Altogether, this work implicates LAMP5 function in
GABAergic neurotransmission in defined neuronal subpopulations.
Introduction
Trafficking of cellular components in a coordinated manner represents a major challenge for
all cells. This problem is particularly evident in the case of neurons where proteins, lipids and
RNA have to be transported over large distances along axons or into highly complex dendritic
arborizations to reach pre- or postsynaptic sites [1]. Once at the synapse, the situation com-
plexifies further, as neuron-to-neuron communication critically depends on efficient vesicular
loading and sorting, high-speed exocytosis and rapid recycling of cellular material and neuro-
transmitter [2]. Finally, synaptic communication is not a linear transformation of an electric
stimulus into neurotransmitter release, but a locally modifiable process, whose plasticity under-
lies learning and memory [3].
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Work over the past decades demonstrated that many mechanisms managing the cellular
traffic of molecules are shared between neurons and other cells [4,5]. For example, the clathrin
system is widely used in plants, yeast and animals to control endocytosis and intracellular traf-
ficking of defined targets in concert with adaptor proteins that specify the cargo [6]. In neu-
rons, clathrin-mediated endocytosis represents the predominant mode of synaptic vesicle
protein internalization [7–9]. However, due to their particular properties neurons need addi-
tional and unique trafficking systems that address their specific needs.
Lysosome Associated Membrane Proteins (LAMPs) represent a family of membrane pro-
teins sharing sequence and structural homology. Prototypic members of this family like
LAMP1 and LAMP2 are widely expressed in many tissues and have been implicated in a vari-
ety of intracellular trafficking events, often, although not exclusively, associated to lysosomal
transport [10–12].
Based on sequence and structural homology LAMP5 (BAD-LAMP/C20orf103) has been
classified as a LAMP-family member. However, in contrast to canonical members of this fam-
ily, that show widespread expression [11], LAMP5 is, at least in rodents, strictly confined to the
brain where it appears at postnatal stages coincidently with synaptogenesis [11,12]. In neurons,
LAMP5 accumulates in distinct intracellular vesicles that do not contain any known markers
of classical intracellular transport pathways and are not targeted to the endosomal/lysosomal
compartment [13]. Interestingly, the LAMP5 orthologue in C. elegans, unc-46, has been shown
to be specifically expressed in synaptic vesicles of GABAergic neurons. Mutations in unc-46
interfere with GABA neurotransmission [14]. Based on the observations that in unc-46
mutants the Vesicular GABA Transporter (VGAT) is miss-localized to non-vesicular compart-
ments and that loading of synaptic vesicles with GABA is deficient, it was proposed that UNC-
46 functions as a trafficking chaperone that targets VGAT to synaptic vesicles [14].
Here we show that in mice LAMP5 protein is specifically expressed in subpopulations of
GABAergic neurons where it localizes at synaptic terminals, overlapping with VGAT. How-
ever, in the absence of LAMP5, VGAT distribution was not affected, arguing against a constitu-
tive role of the protein as a trafficking chaperone for this transporter. In contrast, alterations in
pre-synaptic plasticity and subtle behavioral alterations in mutant mice point towards with a
fine-tuning function of LAMP5 in evoked GABAergic synaptic transmission.
Materials and Methods
Animals
Animal experiments were carried out in accordance to European Communities Council Direc-
tive and approved by French ethical committees (Comité d’Ethique pour l’expérimentation
animale n°14; permission number: 62–12112012). For all experiments, animals were group-
housed (3–6 per cages) under a 12 hours light-dark cycle in a controlled environment. Food
and water were provided ad libitum.
Generation of LAMP5 mutant mice
LAMP5 conditional mutant mice were generated by the KO-KI Booster platform, CIPHE, Mar-
seille (http://www.celphedia.eu/en/centers/ciphe). The detailed procedure can be given on
request. Briefly, the BAC RP-330F10 clone isolated from C57BL/6 genome containing LAMP5
locus was used to construct the targeting vector. LoxP sites were introduced upstream of exon2
and downstream of exon 5 therefore flanking the exons carrying the majority of the coding
sequence. This construct was electroporated into C57Bl/6 embryonic stem cells and clones
were analyzed by Southern blots using 5’ and 3’ probes. Two clones that underwent homolo-
gous recombination were used to produce chimeric mice. Recombinant heterozygous mice
LAMP5 at the Synapse
PLOS ONE | DOI:10.1371/journal.pone.0157052 June 7, 2016 2 / 19
carrying the floxed allele LAMP5flox were either crossed together to produce homozygotes
LAMP5flox/flox mice or crossed with a Cre deleter mice (Swenk et al. 1995) that express Cre dur-
ing early embryogenesis giving rise to heterozygous mice LAMP5+/- carrying a deleted LAMP5
allele, LAMP5-. Mutant mice were obtained after crossing heterozygotes, their wild type litter-
mates were used as control.
In situ hybridization and immunohistochemistry
Animals were deeply anesthetized with an overdose of xylasin/ketamine, then intracardially
perfused with 4% paraformaldehyde (wt/vol) in PBS. The brain were dissected out and further
fixed overnight at 4°C in the same fixative. In situ hybridization was performed on cryostat
15 μm sections as described previously [15] using the IMAGE clone 2588577 to make an anti-
sense RNA probe [13]. For immunohistochemistry, 50 μm floating sections were processed as
described previously [16] using primary antibodies against LAMP5 (mAb 34.2, rat IgG, 1:400,
[17], GAD65 (Goat IgG, 1:1000, R&D Systems), VGlut1 (rabbit IgG, 1:500, Synaptic Systems),
VGAT (rabbit IgG, 1:200, kind gift of B. Gasnier, [18] followed by incubation with correspond-
ing secondary antibodies, Alexa 555-conjugated antibody to rat and Alexa 488- conjugated
antibodies to rabbit or goat (1:500, InVitrogen). Confocal images were taken using confocal
microscope LSM 510 (Zeiss). Co-localization quantification of LAMP5 with GAD65 or VGAT
was obtained from automated image analysis using JacoP plugin on ImageJ (Bolte and Corde-
lières, 2006). Quantification was done on 4 pictures taken on different sections from 2 experi-
ments on one wild type animal. For electron microscopy immunolabeling, animals were
perfused with 3% PFA; 0.2% glutaraldehyde, 50 μm vibratome sections were incubated with rat
mAb34.2 then with anti-rat IgG conjugated to ultrasmall nanogold particles (Aurion). After a
silver enhancement step (Aurion R-Gent SE-EM), these pre-embedded immunolabeled sec-
tions were then processed for transmission electron microcopy. Grids were examined using an
electron microscope Zeiss EM 912 and digital images acquired with CCD camera Gatan Bios-
can model 792.
Tissues, Quantitative PCR and immunobloting
Mice were killed by decapitation and brains were dissected out. OB were recovered first then
the other tissues -striatum, pallidum, Substantia nigra pars reticulata (SNr)- were micro dis-
sected from 300 μm thick vibratome brain sections. All tissues were snap frozen and stored at
-80°C until processed for RNA extraction or used for immunobloting. For quantitative PCR,
RNA was extracted using the miRNAeasy kit (Qiagen) and cDNA was prepared using super-
script III reverse transcriptase (Invitrogen). Quantitative PCR was performed on a BioRad
CFX system using SYBR GreenER qPCR SuperMix (Invitrogen). Hprt was used as a reference
gene. The oligonucleotide used for amplification were LAMP5 forward (ACTGTCACCATGA
TCCTGTCC), LAMP5 reverse (CTGGGGATCTGCACTTGATT), hprt forward (CTGGTGA
AAAGGACCTCTCG) and hprt reverse (TGGCAACATCAACAGGACTC). The experiment
was done twice. Quantification and error bars are generated automatically by BioRad software
from 3 wells per gene per sample.
For immunoblot analysis, tissues were lysed in 50mM Tris pH7.5, 150mMNaCl, 1mM
EDTA, 1% NP40, 0.25% NaDOC in presence of protease inhibitors (Complete, Roche). 20 μg
of protein were immunobloted after separation on 4–12% Bis-Tris acrylamide gels (Novex; Life
Technologies). First, LAMP5 protein was detected with rat mAb34.2 (1:400) as primary anti-
body, anti-rat Fab conjugated to horseradish peroxidase (HRP) as secondary antibody and
visualized by Enhanced ChemiLuminescent detection kit (GE Healthcare). For normalization,
the blot was stripped and Actin protein was detected using a mouse IgG2a anti-Actin antibody
LAMP5 at the Synapse
PLOS ONE | DOI:10.1371/journal.pone.0157052 June 7, 2016 3 / 19
(1:2000; SIGMA) and an anti-mouse IgG2A conjugated to HRP. Quantification of blots was
performed by measuring signal intensity using ImageJ.
Forebrain electroporation and analyses
Plasmid DNA was injected in the ventricule of P1 pups and electroporated in the lateral wall to
target olfactory bulb interneurons precursors as described in Boutin et al, 2008. pCAGGS GFP
plasmid was injected either alone in CD1 wild type P1 pups or together with pCAGGS-Cre
plasmid (kind gift X. Morin) in LAMP5flox/+ or LAMP5flox/flox pups. Twenty eight days post
electroporation the bulb were processed for immunohistochemistry as described above or
directly analyzed to assess spine density. The quantification of the latter was performed on 26
(control) and 27 (mutant) dendrites from 4 animals for each condition.
OB subcellular fractionation and immunoisolation of synaptic vesicles
12 adult mice were killed by decapitation and OB were dissected on ice and placed into an ice
cold sucrose/HEPES buffer (0.32M sucrose; 4mMHEPES/KOH buffer, pH 7.3). Synaptic vesi-
cles were purified as described (Huttner et al. J. Cell Biol, 1983) after subcellular fractionation.
Briefly, the OB were homogenized in ice cold sucrose/HEPES buffer (HSB) in a glass-Teflon
homogenizer. The pellet representing the nuclear fraction was discarded after centrifugation at
1000 g for 10 min and the supernatant (S1) was further centrifuged at 12500 g for 15 min. The
pellet (P2) was resuspended in 10 ml HSB and centrifuged again at 12500 g for 15 min. The
resulting pellet (P2’) constituting the synaptosome fraction was resuspended 0.5ml of HBS.
This fraction was then lysed osmotically in 5 ml of ice cold H2O, homogenized and centrifuged
at 25000 g for 20 min. The supernatant (LS1) representing the synaptic vesicles fraction was
used for immunoisolation of the vesicles. Protein G Plus-agarose beads (Santa Cruz) were cou-
pled to mouse IgG against VGAT (Synaptic Systems) or against NeuN (Chemicon) for control.
The conjugated beads were incubated with LS1 fraction corresponding to 200 μg of proteins,
overnight at 4°C in presence of protease inhibitors (Complete, Roche). After several washes in
PBS, the bound synaptic vesicles were eluted in Laemli buffer. These samples were immuno-
bloted after separation on 4–12% Bis-Tris acrylamide gels (Novex; Life Technologies). The
presence of LAMP5 on the immunoisolated vesicles fraction was then detected using rat
mAb34.2 and the blot was processed as described before.
Electrophysiology
Electrophysiological recordings from 4 to 6 week-old LAMP5 mutant and wild-type (WT) lit-
termate mice were interleaved whenever possible. Parasagittal slices (250 μm) containing the
striatum and the GP were cut with a VT1000 S vibratome (Leica, Wetzlar, Germany) in ice-
cold high-choline artificial cerebro-spinal fluid (ACSF) as previously described [19,20] and
maintained at room temperature until recordings. Slices were then transferred to a submersion
recording chamber and continuously perfused (3 ml/min) with standard ACSF containing (in
mM): 126 NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 25 NaHCO3 and 11 glucose,
gassed with 95% O2 / 5% CO2 and warmed to 33°C (pH 7.4). All recordings were performed in
ACSF + 20 μMCNQX (Sigma-Aldrich), to block glutamatergic transmission, in voltage-clamp
at a holding potential of -50 mV with electrodes (4–6 MO) containing (in mM): 140 CsCl, 10
NaCl, 0.1 CaCl, 10 HEPES, 1 EGTA, 2 Mg-ATP et 0.5 Na-GTP, pH = 7.25, 270–290 mOsm/L.
Miniature inhibitory post-synaptic currents (mIPSCs) were recorded in the presence of 1 μM
tetrodotoxin (TTX), a blocker of voltage-dependent sodium channels. IPSCs were evoked
every 10 seconds in the GP by a stimulating electrode (parallel bipolar electrode, # PBSC0275,
FHC) placed in the striatum. For paired-pulse ratios (PPRs), two stimuli were delivered from
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20 to 150 ms interstimulus interval (ISI) and PPRs were calculated as IPSCs2 amplitude /
IPSCs1 amplitude (10 sweeps average per ISI). Synaptic repetitive stimulation was induced by
trains of stimulation (10 pulses at 20 Hz). Neurons were visualized on an upright microscope
(Nikon Eclipse FN1) equipped with DIC optic using a x40 water-immersion objective. Data
were collected with a MultiClamp 700B amplifier (Molecular Devices).
Data are presented as mean ± standard error of the mean (SEM). Statistical significance was
assessed using a nonparametric test (test of Mann-Whitney, MW) (SigmaStat, v3.1) and a Kol-
mogorov-Sminov test for the cumulative probability distributions. A significance of p< 0.05
was required for rejection of the null hypothesis.
Behavioral studies
All behavioral studies were carried out with wild type and homozygous male littermates
derived from crossing heterozygous LAMP5+/- mice. Mice cohorts grouping individuals born
within two weeks and between 12 to 16 weeks of age were used for rotarod, catalepsy and odor
discrimination tests. For locomotor activity and Elevated Plus maze tests, two independent
cohorts were used, one between 12–14 weeks of age and another between 18–20 weeks. As
inter-cohort statistical analysis did not show any difference, test results from all individuals
were pooled. All studies were performed blind to genotype.
Locomotor activity. Locomotion was assessed in photocell-based activity chambers. Each
mouse was placed in a Plexiglas activity box (18.2x12x22 cm) equipped with infrared sensors,
allowing measurement of ambulatory locomotor activity. Each box was connected to a com-
puter by an electronic interface (Imetronic). Spontaneous activity was measured for 2 hours.
Rotarod test. This test assesses motor co-ordination and balance. In this test, mice have to
keep their balance on a rotating rod under continuous acceleration from 4 rpm to 40 rpm in
300 seconds. Latency of each mouse to fall from the rod is recorded. The test was carried out
following the protocol described in “European Mouse Phenotyping resource of Standardised
Screen” (EMPReSS; "http://empress.har.mrc.ac.uk/). Briefly, after being trained to stay on the
rotating rod set at a stable speed (4 rpm) for one minute, mice started their test session. This
session consisted of 3 trials separated by 10 minutes inter trial intervals. The mean of latency
over the three trials gives the latency reported per animal.
Elevated Plus Maze test (EPM). Anxiety related behavior was measured using the EPM
test as described previously [21]. This test uses the mice natural fear of height and open space
and its preference to dark/enclosed space. Briefly, each mouse was placed in the center of an
elevated maze with four arms (two open and two enclosed) that are arranged to form a plus
shape, and was allowed to freely explore the maze for 5 min. The mouse path was tracked and
automatically analyzed (Videotrack, Viewpoint).
Haloperidol-induced catalepsy. Catalepsy was measured using the catalepsy bar test
[22,23]. Briefly, after intraperitoneal Injection of 1 mg per kg of haloperidol (Haldol 5mg/ml,
Janssen-Cilag), mice were placed in an individual Plexiglass cage. Cataleptic state was measured
by placing the front paws of the animal on a horizontal steel bar (4cm high, 15cm wide). The
length of time the animals stayed in this position was recorded to a maximum of 300 seconds.
After each test, animals were placed back to their Plexiglass cage. Measurements were con-
ducted 15 min after haloperidol administration and then, animals were tested every 20 min for
155 min.
Odor discrimination test. The protocol used is described in [24]. Odor discrimination is
based on a habituation/dishabituation task that consists of four consecutive presentations of a
habituation odorant (Oh) followed by one presentation of a test odorant (Ot). The time that
the mouse spent sniffing the odors at each presentation was recorded. Significant increase of
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the investigation time of the Ot compared to the fourth Oh presentation indicates discrimina-
tion. Three sets of odors were used isoamylbutyrate/heptanol, hexanol/limonene- and isoamy-
lacetate/carvone. Each odorant was diluted 1/1000 in mineral oil.
Quantification and Statistical analysis
Results are expressed as mean ± SEM. In the Rotarod and EPM assays, differences between
groups were assessed by using Kruskal-Wallis statistical test. In the olfaction test, within-sub-
jects analyses of variance (ANOVA) were performed across the four habituation trials, with
trial number as the within-subjects factor and genotype as a between-subjects factor to assess
habituation. Subsequently, Wilcoxon pairwise comparisons were performed to determine
whether mice of each genotype habituated to the habituation odor (Oh) as indicated by a sig-
nificant decrease in investigation time between the first (Oh1) and the fourth (Oh4) odor pre-
sentation. To assess odor discrimination, Wilcoxon pairwise comparisons were performed to
determine whether the investigation time elicited by Ot was significantly increased from that
elicited by Oh during the fourth odor presentation. All data analysis was performed with R
Software (The R Project for Statistical Computing).
Results
LAMP5 is synaptically localized in subpopulations of GABAergic
neurons
In situ hybridization (from Allen Brain Atlas, URL: http://mouse.brain-map.org/) showed stron-
gest expression of LAMP5mRNA in the forebrain in the neocortex, piriform cortex, hippocampus
and striatum (Fig 1A). In addition, the mitral and granule cell layers of the olfactory bulb (OB)
showed high signal levels (Fig 1C). Interestingly, the LAMP5 specific monoclonal antibody mAb
34.2 [17] showed a largely non-overlapping pattern. LAMP5 immunoreactivity was absent from
the cortex, but confined to the globus pallidus (GP)/ventral pallidum (VP) complex as well as the
substantia nigra pars reticulata (SNr, Fig 1B). In the OB the external plexiform layer (EPL) showed
strong LAMP5 immunoreactivity (Fig 1D). This specific distribution was confirmed using micro-
dissected tissue. qRT-PCR analyses using primers within the coding region of LAMP5, and
including the peptide sequence used for immunization, detected high levels of LAMP5mRNA in
the cortex and the striatum, while expression was low in GP and SNr. (Fig 1G). In agreement with
the histological data, western blotting of tissue extracts showed very low levels of LAMP5 immu-
noreactivity in the cortex and striatum but strong expression in GP and SNr (Fig 1H and 1I). OB
was taken as a whole and showed expression of both, mRNA and protein (Fig 1G, 1H and 1I).
The pattern of LAMP5 immunoreactivity based on the m34.2 antibody was in partial con-
tradiction to previous results obtained with a polyclonal rabbit serum [13]. We generated
LAMP5-deficient mice by flanking exons 2–5 with loxP sites and breeding this allele to mice
expressing the CRE recombinase ubiquitously at the early embryonic stage (Fig 2A, [25]. West-
ern blot analyses of brain extracts demonstrated the total absence of mAb 34.2 immunoreactiv-
ity in homozygous KOs and the expected dose reduction in heterozygotes (Fig 2B). Specificity
was further confirmed by immunofluorescence analyses of brain sections, showing that two
structures with highest signal levels, GP and OB (see Fig 1) were negative in KOs. Cortex
showed no specific signal in the WT (Fig 2C). We conclude that m34.2 is LAMP5 specific.
Altogether, the above results indicate that LAMP5mRNA was present in subpopulations of
both GABAergic and glutamatergic neurons in the forebrain. However, in the cortex, hippo-
campus and the OB mitral cell layer, LAMP5 protein was absent. The situation was different
for the striatal LAMP5mRNA positive cell populations. Here, LAMP5 protein was non-
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detectable in the striatum itself, but was strongly expressed in the main output structures for
GABAergic striatal neurons, the GP/VP and SNr (Fig 1E). Since these structures were negative
for LAMP5mRNA, this indicated synaptic localization of LAMP5 protein in striatal neurons.
In the OB, the protein was confined to the EPL, the layer in which GABAergic interneurons of
the granule cell layer form synapses with mitral and tufted cells (Fig 1F; [26]. This, again, sug-
gested synaptic targeting of LAMP5 protein.
We aimed at validating this distribution at higher resolution using immunofluorescence
and electron microscopy. In both, the GP and the EPL of the OB, LAMP5 immunostaining
showed the typical punctate aspect indicative of synaptic localization (Fig 3A–3C and 3E). In
the GP co-staining for glutamate-decarboxylase 65 (GAD65), a GABA-synapse specific pro-
tein, revealed that 69.1 +/- 3.9% of the LAMP5 positive punctae labeled also for this presynaptic
marker (n = 4; Fig 2A). Staining for the glutamatergic synapse marker VGLUT1 was always
non-overlapping with LAMP5 (Fig 3B and 3E).
Fig 1. Differential expression of LAMP5mRNA and protein in the brain. (A,C) In situ hybridization and
(B,D) immunohistochemistry for LAMP5 on sagittal brain sections (A,B) and on coronal olfactory bulb (OB)
sections (C,D). Strongest expression of LAMP5mRNA is found in the neocortex (CX), piriform cortex (Pir),
hippocampus (Hp), striatum (ST) and the granular cell layer (GCL) of the OB. LAMP5 protein is strongly
present in the Globus Pallidus/Ventral Pallidum complex (GP/VP), the Substantia Nigra pars reticulata (SNr)
and the entopeduncular nucleus (EP), that are the main output structures of the striatal GABAergic projection
neurons, and in the external plexiform layer (EPL), in which granule cells positioned in the granule cell layer
(GCL) form GABAergic synapses. (E-F) Schematic representation of LAMP5mRNA (light grey) and protein
(dark grey) expression in the rodent forebrain (E) and OB (F). (G) qRT-PCR analysis of LAMP5 expression in
different brain tissue samples. Coherent with immunohistochemical stainings, strongest expression of
LAMP5mRNA is detected in the cortex, striatum and the OB. (H) Western blotting and its quantification (I)
demonstrates that LAMP5 protein is strongly expressed in GP and SNr while striatal tissue (ST) and cortex
show only weak signal. Th: thalamus; Scale bar: 1 mm in A,B; 0.5 mm in C,D.
doi:10.1371/journal.pone.0157052.g001
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Next we combined immunofluorescence for LAMP5 with in vivo brain electroporation in
the OB neurogenic system, which allows visualization of synaptic contacts of OB granule cells
at high resolution. A GFP expression construct was electroporated in neural stem cells of the
lateral ventricular wall at postnatal day 1 (P1) as described before [27,28]. Twenty one days
later GFP positive GABAergic granule neurons derived from the labeled stem cells were found
in the OB and formed dendritic spines contacting shafts of mitral cells within the EPL [26].
The majority of these newly formed spines were immunoreactive for LAMP5 (Fig 3C and 3C’).
To further increase resolution, we used immunogold electron microscopy. Gold particles
linked to the LAMP5 antibody were always associated with the typical synapses that granule
neurons in the OB form on the apical dendrites of mitral cells (Fig 3D). Moreover, like in the
GP, labeling of LAMP5 and the glutamatergic marker VGLUT1 showed little to no co-localiza-
tion in the OB (Fig 3E). Altogether, these data indicate that sub-populations of forebrain
GABAergic neurons in the striatum and OB express LAMP5 specifically at their synaptic
contacts.
LAMP5 is not essential for correct localization of VGAT
In C. elegans, the LAMP5 orthologue UNC-46 has been implicated in trafficking of the vesicu-
lar GABA-transporter UNC-47 to synaptic vesicles [14]. We investigated the relation of
LAMP5 with the mouse orthologue of UNC-47, the vesicular GABA transporter VGAT.
Immunofluorescence in both, the GP and the EPL of the OB, showed that expression of VGAT
largely overlapped with LAMP5 (Fig 4A). Quantitative evaluation demonstrated that 76.8 +/-
2.4% and 87.1 +/-3.6% of all LAMP5 positive punctae co-labeled for VGAT in the OB and in
the GP respectively (Fig 4B), indicating the presence of both molecules at the same synapses.
We used synaptic vesicle-immunoisolation to investigate if both molecules were present in the
same vesicles. Pull-down of the VGAT positive vesicles from the adult OB followed by western
blotting demonstrated the presence of LAMP5 in the precipitated fraction (Fig 4C).
Fig 2. LAMP5 deficient mice validate mAb 34.2 anti-LAMP5 antibody specificity. (A) Targeting strategy to generate a LAMP5
deficient mouse line. The targeting vector was designed to remove exons 3–5 after CRE-induced recombination, leading to a null allele.
LAMP5 null animals are viable and therefore used for most analyses. (B) Western blot of KO (-/-), heterozygote (+/-) and wild type (+/+)
mouse brains demonstrates absence of protein in homozygous KOs. (C) Immunohistochemistry with mAb 34.2 anti-LAMP5 antibody on
LAMP5+/+ and LAMP5-/- tissue sections of GP and OB validates the absence of LAMP5 protein in KOs. Cortex was always negative.
Scale bars: C, 200 μm for GP and OB; 100 μm for cortex.
doi:10.1371/journal.pone.0157052.g002
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In conclusion, these data suggest that LAMP5 is expressed in subpopulations of GABAergic
neurons where it largely co-localizes in synaptic vesicles with VGAT. Thus, expression and cel-
lular localization of the protein was in agreement with a function in GABAergic synaptic trans-
mission. However, expression of LAMP5 was restricted to specific inhibitory subpopulations in
the striatum and the OB, but not pan-GABAergic, since GABAergic structures like SNr or GP
Fig 3. LAMP5 is specifically expressed in GABAergic synapses. (A) Immunofluorescence labeling for LAMP5
and GAD65 proteins demonstrates co-labelling in GABAergic axon terminals in the GP (arrowheads). (B) LAMP5
immunoreactivity never overlaps with vGLUT1 (arrowheads), thus it is absent from glutamatergic synapses. (C, C')
In the OB, LAMP5 is localized on the synapses (arrowheads) of newly generated granule neurons, labeled with
GFP by in vivo brain electroporation. (D) Electron microscopy immunogold labeling validates synaptic localization
of LAMP5. Electron dense gold particles are always associated with symmetric synaptic densities (arrow) typical of
GABAergic synapses formed by granule neurons onto mitral cell dendrites. (E) Like in the GP, glutamatergic
synapses in the OB are devoid of LAMP5 staining (arrowheads). Scale bars: 5 μm in A,B,C,E, F; 0,1 μm in D.
doi:10.1371/journal.pone.0157052.g003
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were negative for the mRNA. This argued against a generalized role as an essential trafficking
factor for VGAT.
To further investigate this point we analyzed VGAT localization in the LAMP5-deficient
brains. In both, the GP and the OB distribution and quantity of VGAT was unaffected by the
absence of LAMP5 (Fig 5). Thus, LAMP5-deficiency in mice did not induce detectable changes
in the sub-cellular localization of VGAT.
Altered synaptic plasticity in the absence of LAMP5
Constitutively LAMP5 knock out (KO) mice were born at Mendelian ratio and showed no
gross morphological alterations. Histological observations of brain sections based on Nissl-
staining revealed that overall brain structure was unaffected (Fig 6A). Moreover, the indistin-
guishable distribution of VGAT in GP and OB (Fig 5) indicated normal synaptic organization.
Fig 4. LAMP5 is present on VGAT positive synaptic vesicles. (A) Histological sections of the GP and the
OB immunostained for LAMP5 and VGAT. LAMP5 labeling largely overlaps with VGAT immunoreactivity in
both structures (arrowheads) (B) Quantitative evaluation of synaptic puncta shows that the vast majority of
LAMP5 positive synapses co-express VGAT (n = 4 photomicrographs for GP and for OB). (C)
Immunoisolation of vesicles using a VGAT antibody followed by western blotting. LAMP5 is specifically found
in the VGAT positive fraction. Scale bar: 5 μm.
doi:10.1371/journal.pone.0157052.g004
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Therefore, we asked if LAMP5-deficiency induced a selective disadvantage leading to mor-
phological alterations when KO neurons had to integrate in a competitive context, as demon-
strated before in the case of the proteoglycan Agrin [28]. As mentioned above, during
postnatal neurogenesis in the OB new interneurons are permanently generated by neural stem
cells situated along the walls of the lateral ventricles. After their migration they integrate in the
OB circuitry. Postnatal brain electroporation allows the efficient expression of transgenes in a
Fig 5. LAMP5 knockout mice show normal VGAT distribution. (A, B) Immunostaining of LAMP5 and VGAT on GP (A) and OB (B)
histological sections show no change in tissue and subcellular distribution in the absence of LAMP5. (C) Signal intensity of VGAT staining
in the GP and in the OB, assessed by ImageJ analysis, is also unchanged. Mean intensity was calculated over 3 photomicrographs. Scale
bar: A, 100 μm (left), 5 μm (right); C, 50 μm (left), 5 μm (right).
doi:10.1371/journal.pone.0157052.g005
Fig 6. Absence of LAMP5 does not alter brain structure nor spine density in the OB. (A) Cresyl violet staining of forebrain and OB
sections shows no obvious structural changes in the brain in the absence of LAMP5. (B) Dendrites of control (LAMP5 flox/+) and mutant
(LAMP5 flox/flox) newly generated granule neurons observed in the EPL of the OB 28 days after their electroporation (28dpe) with GFP
and Cre recombinase expression plasmids. (C) Quantification of spine density on the dendrites of control (CTL) and KO newly integrated
neurons. Dendrite morphology and spine density are unchanged in LAMP5 KO. Dendrites n = 26 (flox/+) and 27 (flox/flox). Statistics:
Wilcoxon test p-value = 0.9645. Scale bars: A, 1mm (0.5 mm for the OB); B, 20 μm (left), 5 μm (right). ST: Striatum; Th: Thalamus.
doi:10.1371/journal.pone.0157052.g006
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subpopulation of these neuronal lineages (compare Fig 4C). We used this approach to create a
situation in which individual LAMP5 KO cells had to form synapses in a WT context. To do so
we electroporated a CRE recombinase expressing plasmid (together with GFP reporter plasmid
that is co-transfected in almost all cells, Boutin et al., 2008) at P0 in the ventricular wall of mice
that were either heterozygous for the targeted LAMP5 locus (+/floxed) or homozygous for the
floxed allele (floxed/floxed). Twenty eight days later, offspring of the targeted cells were ana-
lyzed after their integration into the OB. These analyses demonstrated that neuronal morphol-
ogy (Fig 6B) and spine density (Fig 6C) were indistinguishable among both genotypes. Thus,
even in a competitive context LAMP5 deficiency did not lead to detectable morphological
alterations.
Given the synaptic localization of LAMP5 and its proposed function as a VGAT transporter
in C. elegans, we tested whether LAMP5 was important for synaptic physiology, thereby focus-
ing on the striatopallidal synapse. We first quantified miniature inhibitory postsynaptic cur-
rents (mIPSCs) in GP neurons in the presence of 1 μMTTX to block activity-dependent
release of neurotransmitter in WT and KOmice. While mIPSCs amplitudes were similar in
WT and KOmice, we observed a statistically significant increase in the frequency of mIPSCs in
KO mice (Fig 7A), suggesting a change in the presynaptic release apparatus. We then analyzed
Fig 7. Short-term plasticity of the striatopallidal synapse is altered in LAMP5 deficient mice. (A) Top:
Representative traces of mIPSCs fromWT and KOmice. Bottom: Cumulative inter-event interval (left) and
amplitude (right) distributions of mIPSCs obtained in WT and KOmice (n = 400 events per cell). The frequency of
mIPSCs is significantly increased in LAMP5 KO compared to WTmice (p < 0.001; WT amplitude n = 3 mice, n = 4
slices, n = 7 cells / KO amplitude n = 2 mice, n = 4 slices, n = 5 cells; WT frequency n = 3 mice, n = 4 slices, n = 7
cells / KO frequency n = 2 mice, n = 4 slices, n = 6 cells). (B) Parasagittal section of the mouse brain showing the
recording and stimulation sites. Evoked striatopallidal GABAergic IPSCs are blocked by the GABAA receptor
antagonist, picrotoxin (ptx). St: striatum, GP: globus pallidus. (C) Mean PPR values fromWT and KOmice at
different interstimulus intervals. Sample traces of PPR are shown above the graph (traces were scaled to first
IPSCs). * p < 0.05, ** p < 0.01 vs. WTmice. (D) Synaptic depression during repeated stimulation (10 pulses at 20
and 50 Hz) in WTmice was replaced by facilitation in KOmice. Representative traces to 20 and 50 Hz trains are
shown in WT and KOmice. * p < 0.05, ** p < 0.01 vs. WTmice. Error bars represent SEM.
doi:10.1371/journal.pone.0157052.g007
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evoked IPSCs triggered by striatal stimulation in GP neurons. Such stimulation elicited inward
IPSCs that were blocked by the GABAA antagonist picrotoxin (Fig 7B). As LAMP5 is specifi-
cally expressed in striatal terminals, presynaptic function of the GABAergic striatopallidal syn-
apse was investigated by using short-term plasticity protocols. The results showed that paired-
pulse ratios (PPRs) of IPSCs, a standard measure of neurotransmitter release probability, were
strongly affected in LAMP5 KOmice. The moderate paired-pulse depression of striatopallidal
synapses observed in WTmice was replaced by a strong facilitation in LAMP5 KOmice at all
four interstimulus intervals (Fig 7C). This suggests that deletion of LAMP5 decreases release
probability, the most common cause for paired-pulse facilitation [29].
We then investigated the behavior of striatopallidal synapses during trains of stimuli at
moderate frequency (10 pulses at 20 and 50 Hz). In these experiments synapses showed fre-
quency-dependent short-term depression in WTmice (Fig 7D). Conversely, LAMP5-deficient
mice exhibited a pronounced augmentation for the entire duration of the train, both at 20 and
50 Hz (Fig 7D). Altogether, these results suggest that LAMP5 appears critical for the regulation
of spontaneous vesicular release and the dynamics of evoked GABAergic transmission, espe-
cially during periods of moderate activity.
Behavioral analyses
Finally, we used set of behavioral tests to investigate if loss of LAMP5 and the consequent defi-
cits in synaptic transmission led to alterations at this level. Since the striatal projection systems,
that expresses high levels of LAMP5 (Fig 1), is implicated in motor control, we first focused on
this aspect. General locomotor activity and exploratory behavior were measured in an activity
test, where animals were allowed to explore the test environment for two hours. As expected,
total exploratory activity decreased over the test interval. Significant differences between con-
trol and LAMP5 KO were not detectable (Fig 8A). We investigated motor coordination and
endurance using a Rotarod test. Again, latency to fall off the rotating cylinder was not different
between WT and LAMP5 KO (Fig 8B). Thus, significant alterations in activity and motor coor-
dination were not detectable in the absence of LAMP5.
LAMP5 is expressed in the axon terminals of two populations of striatal neurons that connect
directly and indirectly (via two relays: GP and subthalamic nucleus, STN) the basal ganglia out-
put structures SNr and EP. Striatal “direct” and “indirect” neurons exert opposite influence onto
basal ganglia outflow, and consequently on motor function. Therefore, by affecting GABA trans-
mission at synapses established by direct and indirect striatal neurons, LAMP5 deficiency per se
might not disrupt the excitation/inhibition balance in the basal ganglia output structures. This is
in agreement with the lack of motor deficits in KOmice under basal conditions. We tested the
consequences of LAMP5 deficiency in a model of imbalanced activity between the two pathways.
Striatal neurons of the direct pathway express predominantly D1 dopamine receptors while stria-
tal neurons in the indirect pathway express preferentially D2 dopamine receptors (D2R). The
antipsychotic haloperidol depresses motor function and induces a cataleptic state primarily
attributed to the drug’s high potential to block striatal D2R (Sanberg Nature 1980, Wadenberg
et al., 2001). According to the schemes of basal ganglia functioning (Albin et al., 1989), such
blockade would increase striatal indirect neuron activity, unbalancing the system towards excita-
tion of basal ganglia output structures and hence would result in inhibiting motor function. In
this context, LAMP5-deficiency is expected to reduce haloperidol-induced catalepsy. We per-
formed intra-peritoneal injection of haloperidol in KO (n = 12) and control (n = 8) mice but did
not detect a statistically significant reduction in cataleptic state in mutants (Fig 8C).
Next, we performed the elevated Plus-maze test, a well-established assay of anxiety-related
behavior in rodents [30] [31]. Here, WT and KO behaved not significantly different concerning
LAMP5 at the Synapse
PLOS ONE | DOI:10.1371/journal.pone.0157052 June 7, 2016 13 / 19
Fig 8. Absence of LAMP5 disrupts olfaction and leads to anxiety-like behavior. (A) Spontaneous activity of
naive wild type (open circles) and KOmice (dark circles). Horizontal locomotor activity is recorded every 10 min for
2 hours. The exploration is similar over time betweenWT (n = 11) and KO (n = 16). (B) Motor coordination is
assessed in a rotarod essay where mice are placed on a cylinder that rolls at increasing speed with time. The
latency before the mice fall is measured. No difference is found betweenWT (n = 8) and KO (n = 7) mice. Kruskal-
Wallis test p-value = 0.4875. (C) Catalepsy test. WT and KOmice are injected with haloperidol (i.p. 1mg/kg). The
length of time the animals stay in a constrained position is recorded to a maximum of 300 seconds every 20 min.
(WT n = 7; KO n = 7). ANOVA testing shows no genotype effect (F1,13 = 0.213, p-value = 0.652) and no interaction
between time and genotype (F7,91 = 0.558; p = 0.788). (D) Elevated Plus Maze test. Left: Total number of entries in
closed and open arms, an index of activity. Middle: percentage of time spent into the open arms. Right: percentage
of open arm entries. The mutant mice are less anxious as they spend significantly more time exploring the open
arms (Kruskal-Wallis test p-value = 0.01221) and enter preferentially into the open arms (Kruskal-Wallis test p-
value = 0.03415; WT n = 11, KO n = 16). (E) Odor discrimination test. A first odorant (Oh: habituation odor) is
presented for four consecutive trials followed by the presentation of a test odor (Ot). The time spent by the mice
investigating the respective odorant is recorded. Habituation occurs similarly for both WT and KOmice as shown
by a significant decrease in investigation time between the first (Oh1) and last (Oh4) trials (*, p<0.05; **, p<0.01;
***, p<0.001). Discrimination is partially impaired in KOmice as they do not discriminate between isoamyl butyrate
and heptanol or between hexanol and limonene- (Ot vs Oh4: $, p<0.05; $ $, p<0.01; ns: not significant). Statistics:
Wilcoxon test. Number of animals: isoamyl butyrate/ heptanol WT n = 14, KO n = 27; hexanol/limoneneWT n = 10,
KO n = 13; isoamyl actetate/carvonWT n = 7, KO n = 7. Error bars represent SEM.
doi:10.1371/journal.pone.0157052.g008
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total arm entries, in agreement with unaltered locomotor activity. However, mutants entered
open arms more frequently and spent more time in these compartments (Fig 8D), suggesting
decreased anxiety levels.
Finally, we tested olfactory capacities of LAMP5-deficient mice. Correct function of
GABAergic inhibition by granule neurons in the OB has been shown to be crucial for efficient
odor discrimination [32]. Given that OB granule neurons represent one of the few cell popula-
tions that express high LAMP5 levels at their synapses, we next tested odor discrimination
using three pairs of odors (odor pair 1: isoamyl butyrate/ heptanol; odor pair 2: hexanol/limo-
nene; odor pair 3: isoamyl actetate/carvon). All animals presented solid habituation to the first
odor over four successive trials as demonstrated by ANOVA analyses showing a significant
effect of trial number across habituation trials (odor pair 1: F3,3 = 51.807, p<0.001; odor pair 2:
F3,3 = 41.536, p<0.001; odor pair 3: F3,3 = 16.99, p<0.001). Interaction between trials and geno-
type was not detected except for odor 2, due to a significant difference in investigation time
during the first odor presentation (odor pair 1: F3,117 = 0.323, p = 0.809; odor pair 2: F3,63 =
5.142, p = 0.003; odor pair 3: F3,48 = 1.04, p = 0.383). Nonetheless, habituation occurred and
the significant decrease in odor investigation time between the first (Oh1) and last (Oh4) trials
was confirmed by Wilcoxon post hoc comparisons (Fig 8E). However, while wild type animals
were in all situations able to distinguish the new test odor (Ot), LAMP5 KO showed no signifi-
cant discrimination for two out of three odors, heptanol and limonene- (Fig 8E).
In conclusion, LAMP5-deficient mice showed normal activity and motor behavior but had
decreased anxiety levels. Moreover, in agreement with the restricted expression of LAMP5 pro-
tein at OB inhibitory synapses, we identified minor deficits in odor discrimination.
Discussion
We found that LAMP5 is confined to sub-populations of GABAergic neurons where it shows
synaptic localization. LAMP5-deficency in mice does not affect overall brain morphology or
lead to detectable structural or connectivity changes in the analyzed LAMP5-positive neuron
populations, but induces subtle alterations in synaptic plasticity and behavior.
In C. elegans the LAMP5 orthologue UNC-46 has been suggested to play an essential role in
loading of GABA containing synaptic vesicles through the correct trafficking of VGAT [14]. This
conclusion was based on several lines of evidence. First, unc-46 is expressed by all 26 GABAergic
neurons, which, however, develop normally in its absence. Second, the synaptically localized pro-
teins VGAT and UNC-46, were mislocalized to non-synaptic compartments in the absence of
the respective other protein, suggesting an interaction between both molecules that controls their
sub-cellular targeting. Third, in unc-46mutants the frequency of GABAminiature currents was
reduced by 90%, while amplitude of the remaining minis was normal. This indicates that in the
absence of the protein a smaller number of synaptic vesicles is filled with neurotransmitter, but
that these vesicles contain normal GABA concentrations. Lastly, overexpression of VGAT was
able to rescue the locomotion defects induced by unc-46 deficiency.
In agreement with the data in nematodes, our data supports a function of LAMP5 in
GABAergic neurons in mice. The protein is confined to GABAergic synapses and GABAergic
synaptic transmission is affected in its absence. However, it is also evident that this function is
distinct from its supposed role in the worm. In both species, LAMP5 co-localizes with VGAT
in GABAergic synaptic vesicles. But, unlike VGAT and other than in the worm, LAMP5 is not
expressed by all GABAergic neurons, but is confined to subsets, arguing more for a specific reg-
ulatory role than for a general function in transporter trafficking. Moreover, while in the worm
UNC-47 is miss-targeted in unc-46mutants, in the absence of LAMP5 in mice VGAT shows
its normal localization in brain structures that normally co-express both molecules, like the GP
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and the OB. This, again, argues against a general role of LAMP5 in transporter trafficking from
ER to the synapse and might be indicative of a tailor-made function potentially affecting
VGAT activity in a subset of synaptic vesicles or at a specific time of GABA release.
Furthermore, while activity-independent release of GABA is severely affected in unc-46
mutants, our data in KO mice implicate LAMP5 in a more subtle regulation of inhibitory syn-
aptic transmission. When recording GP neurons, the main target of striatal terminals express-
ing high level of LAMP5, we found that the frequency of mIPSCs was not decreased but
increased in LAMP5 knockout mice while amplitude distribution was not changed. Surpris-
ingly, the transition from moderate paired-pulse depression in WTmice to facilitation in
LAMP5 knock-out mice indicates that the deletion of LAMP5 decreases the release probability
at striatopallidal synapses. Short-term plasticity of these synapses was also affected in the
absence of LAMP5, switching from depression in WT to augmentation in LAMP5 knockout
mice, when responding to train stimulation. Altogether, these observations suggest that
LAMP5 acts in the regulation of GABAergic transmission at the presynaptic level and that
activity-independent and evoked release processes are differentially dependent on its presence.
Numerous mechanisms contribute to short-term plasticity including regulation of vesicle avail-
ability and calcium homeostasis in nerve terminals (Fioravante and Regehr, 2011). Although it
is difficult to predict at this point which steps of the release machinery are modulated by
LAMP5, our results highlight a critical role for this protein in regulating GABAergic transmis-
sion in the central nervous system. Consistent with such a critical function in fine-tuning spe-
cific GABAergic synapses, LAMP5 KOmice show subtle behavioral abnormalities, as
evidenced by decreased anxiety and altered odor discrimination. This correlates with LAMP5
expression in the ventral pallidum, that processes motivational and emotional information,
and in OB granule cells that are implicated in odor discrimination (Shepherd, Greer, 2007).
While our data points clearly to a regulatory function of LAMP5 in induced synaptic trans-
mission in subsets of GABAergic synapses, more detailed cell biological analyses are hampered
by the lack of suitable cellular models. High-resolution analyses depend on the availability of in
vitro models that can be studied in terms of protein interactions and localization. LAMP5 is
expressed only at late stages of brain development, when synapses mature and start to function
[13]. We observed that LAMP5 expression is never induced in cultured olfactory bulb primary
neurons, suggesting that even when synaptic contacts are formed induction of LAMP5 expres-
sion might depend either on the presynaptic activity of the GABA neuron or on specific retro-
grade signals from the other components of the synapse: the post-synaptic neuron or the glial
cells surrounding the functional synapse.
Given the paucity of suitable neuronal in vitro models, most information about the cellular
function of LAMP5 relies on observations in the human immune system and on gain-of-func-
tion studies in non-neuronal HeLa cells. In the human immune system LAMP5 is expressed at
high levels in plasmacytoid dendritic cells (pDCs), where it allows discrimination of normal
from leukemic pDCs in tissue and blood [17]. At the molecular level, human pDCs express
high amounts of UNC-93B1, a protein implicated in toll-like receptor (TLR) trafficking, which
is related to the C. elegans protein F31D5.2. The latter factor has been identified as a direct
binding partner for LAMP5 using two-hybrid studies in the worm [33].
Interestingly, gain-of-function studies in HeLa cells demonstrated that LAMP5 is, when
expressed alone, predominantly present at the cell membrane while UNC-93B1 accumulates in
the ER. Co-expression of both molecules induces their redistribution into LAMP1-positive endo-
somes, altogether indicating that they function as co-chaperones that reciprocally influence their
intracellular addressing (Defays et al., 2011). Therefore, while our data results argue against a
major role in trafficking of the GABA-transporter VGAT to synaptic vesicles, a role of LAMP5 as
a trafficking chaperone for other cargo or to reach other organelles could still be contemplated.
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Another important observation concerns the regulation of LAMP5 protein expression.
Highest mRNA levels are observed in the neo- and piriform cortex, the hippocampal CA1/
CA3 regions and the mitral cells of the OB. All these populations contain predominantly gluta-
matergic neurons. However, none of these populations expresses considerable amounts of
LAMP5 protein, neither in their cell bodies nor in their synapses. How could this strict sup-
pression of protein production be achieved? One typical mechanism for posttranslational regu-
lation represents microRNA targeting the mRNA. However, scanning the LAMP5 mRNA for
potential microRNA binding sites revealed only one potential target sequence for microRNAs
that so far has not been involved in brain development and function. Moreover, in general
microRNAs modulate expression levels of a given target gene, but do not induce a total sup-
pression, as we see in the case on LAMP5 in glutamatergic neurons. Therefore, we do not favor
such a mechanism. A more likely explanation might lie in the potential function of LAMP5 as
a trafficking chaperone in GABAergic synapses. In the absence of suitable cargo, LAMP5
might well be targeted to the lysosome and degraded.
In conclusion, we describe the expression of Lamp5 at high resolution and its molecular
context. Functional analysis based on conditionally Lamp5 knockout mice indicate a subtle but
detectable role in GABAergic synapse function, leading to consequences at the behavioral level.
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